Thermo Fisher Scientific Inc. has announced that its new Thermo Scientific STP 420ES Tissue Processor for high-throughput tissue processing has been independently validated for xylene-free protocols.
The Global Tissue Diagnostics Market is projected to grow at a CAGR of 7% by 2026. The market expansion is driven by the increasing prevalence of cancer and neoplastic diseases, rising demand for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback